AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2014
Dec 16, 2014
29745_dirs_2014-12-16_7579f737-19ff-4d9d-8968-8a133f431266.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2014-12-10
Reporting Person: Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-10 | Common Stock | F | 5474 | $72.21 | Disposed | 74363 | Direct |
Footnotes
F1: This amendment is being filed to correctly report the amount disposed in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29